Groowe Groowe / Newsroom / GV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

GV News

Visionary Holdings Inc. Common Shares

CORRECTION – Visionary Holdings Inc.

globenewswire.com
GV

Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report

globenewswire.com
GV

Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market

globenewswire.com
GV

Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market

prnewswire.com
GV

Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing

prnewswire.com
GV

Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation

prnewswire.com
GV, hereinafter referred to as "Visionary" or the "Company" GV GV

Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market

prnewswire.com
GV GV

Visionary Holdings (Asia) Limited Enters Into a Strategic Cooperation Agreement with Local Accelerator Qianxin Bocheng (Jiangsu) to Advance the Aesthetic Treatment Industry

prnewswire.com
GV

Visionary Holdings (Nasdaq: GV) Announces a Breakthrough Strategic Alliance With Yike Regenerative Medicine to Unlock the Trillion-Dollar Cellular Rejuvenation and Aesthetic Treatment Market

accessnewswire.com
GV